Utah Medical Products, Inc.
UTMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $208,431 | $188,405 | $185,492 | $208,260 |
| - Cash | $84,267 | $82,179 | $83,325 | $82,976 |
| + Debt | $241 | $256 | $269 | $282 |
| Enterprise Value | $124,405 | $106,482 | $102,436 | $125,566 |
| Revenue | $9,812 | $9,953 | $9,710 | $9,158 |
| % Growth | -1.4% | 2.5% | 6% | – |
| Gross Profit | $5,060 | $5,056 | $5,538 | $5,323 |
| % Margin | 51.6% | 50.8% | 57% | 58.1% |
| EBITDA | $4,062 | $4,581 | $4,188 | $3,984 |
| % Margin | 41.4% | 46% | 43.1% | 43.5% |
| Net Income | $2,631 | $3,048 | $3,041 | $2,902 |
| % Margin | 26.8% | 30.6% | 31.3% | 31.7% |
| EPS Diluted | 0.82 | 0.94 | 0.92 | 0.86 |
| % Growth | -12.8% | 2.2% | 7% | – |
| Operating Cash Flow | – | $2,873 | $4,464 | $2,937 |
| Capital Expenditures | – | -$51 | -$184 | -$9 |
| Free Cash Flow | – | $2,822 | $4,280 | $2,928 |